A Boost for Clinical Trials in the UK
The Medicines and Healthcare products Regulatory Agency (MHRA) set out on 13 January 2026, the next phase of reforms aimed at strengthening the clinical trial landscape in the UK. These reforms come at a time of renewed momentum for clinical research.
A Boost for Clinical Trials in the UK Read More »